Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study
Active, not recruitingOBSERVATIONAL
Enrollment
9,690
Participants
Timeline
Start Date
November 19, 2018
Primary Completion Date
December 31, 2031
Study Completion Date
December 31, 2032
Conditions
Type1diabetesCeliac Disease
Trial Locations (1)
00029
Hospital District of Helsinki and Uusimaa, Helsinki
All Listed Sponsors
lead
University of Helsinki
OTHER
NCT04958356 - Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Celiac Disease and Prospective Follow-up Study | Biotech Hunter | Biotech Hunter